Themis Medicare Limited Net Assets

Latest as of March 2026: Rs3.99 Billion INR ≈ $43.11 Million USD

Themis Medicare Limited net assets. Based on the latest financial reports, Themis Medicare Limited (THEMISMED) has net assets worth Rs3.99 Billion INR (≈ $43.11 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs5.98 Billion ≈ $64.66 Million USD) and total liabilities (Rs1.99 Billion ≈ $21.56 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Themis Medicare Limited (THEMISMED) equity growth momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs3.99 Billion
% of Total Assets	66.66%
Annual Growth Rate	9.88%
5-Year Change	38.64%
10-Year Change	230.88%
Growth Volatility	19.17

Net Assets of Themis Medicare Limited (2006–2026)

Net assets of Themis Medicare Limited from 2006 to 2026. This chart illustrates how Themis Medicare Limited's net assets have evolved over time, based on quarterly financial data. See Themis Medicare Limited net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Themis Medicare Limited (2006–2026)

The table below shows the annual net assets of Themis Medicare Limited from 2006 to 2026. For live market cap and overall valuation, see Themis Medicare Limited (THEMISMED) total market value.

Year	Net Assets	Change
2026-03-31	Rs3.99 Billion ≈ $43.11 Million	-1.00%
2025-03-31	Rs4.03 Billion ≈ $43.54 Million	+6.60%
2024-03-31	Rs3.78 Billion ≈ $40.84 Million	+11.26%
2023-03-31	Rs3.39 Billion ≈ $36.71 Million	+18.07%
2022-03-31	Rs2.87 Billion ≈ $31.09 Million	+31.57%
2021-03-31	Rs2.19 Billion ≈ $23.63 Million	+19.39%
2020-03-31	Rs1.83 Billion ≈ $19.79 Million	+15.78%
2019-03-31	Rs1.58 Billion ≈ $17.09 Million	-6.39%
2018-03-31	Rs1.69 Billion ≈ $18.26 Million	+40.17%
2017-03-31	Rs1.20 Billion ≈ $13.03 Million	+52.70%
2016-03-31	Rs788.89 Million ≈ $8.53 Million	+33.92%
2015-03-31	Rs589.08 Million ≈ $6.37 Million	+4.85%
2014-03-31	Rs561.85 Million ≈ $6.08 Million	+4.59%
2013-03-31	Rs537.17 Million ≈ $5.81 Million	-7.51%
2012-03-31	Rs580.79 Million ≈ $6.28 Million	-36.20%
2011-03-31	Rs910.26 Million ≈ $9.84 Million	+9.22%
2010-03-31	Rs833.43 Million ≈ $9.01 Million	-9.28%
2009-03-31	Rs918.65 Million ≈ $9.93 Million	+8.60%
2008-03-31	Rs845.93 Million ≈ $9.15 Million	+22.31%
2007-03-31	Rs691.60 Million ≈ $7.48 Million	+14.27%
2006-03-31	Rs605.21 Million ≈ $6.55 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Themis Medicare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 253423500000.0% over the analyzed period, indicating profitable operations and earnings retention.

Themis Medicare Limited Net Assets Breakdown (March 2026)

Themis Medicare Limited net assets breakdown by equity component as of March 2026.

Component	Amount	Percentage
Retained Earnings	Rs2.53 Billion	63.58%
Common Stock	Rs92.10 Million	2.31%
Other Comprehensive Income	Rs1.00 Billion	25.14%
Other Components	Rs357.42 Million	8.97%
Total Equity	Rs3.99 Billion	100.00%

Themis Medicare Limited Competitors by Market Cap

The table below lists competitors of Themis Medicare Limited ranked by their market capitalization.

Company	Market Cap
SD Standard Drilling PLC OL:SDSD	$99.34 Million
Bank Capital Indonesia Tbk JK:BACA	$99.38 Million
Goknur Gida Maddeleri Enerji Imalati Ithalat Ihracat Ticaret ve Sanayi A.S. IS:GOKNR	$99.40 Million
First Steamship Co Ltd TW:2601	$99.41 Million
Kencana Agri Limited F:KEBA	$99.31 Million
Team Precision Public Company Limited BK:TEAM	$99.28 Million
Voss Veksel og Landmandsbank ASA OL:VVL	$99.25 Million
Leaders Technology Investment Co. Ltd KQ:019570	$99.24 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Themis Medicare Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 4,026,011,000 to 3,985,838,000, a change of -40,173,000 (-1.0%).
Net income of 11,439,000 contributed positively to equity growth.
Dividend payments of 46,020,000 reduced retained earnings.
New share issuances of 1,818,000 increased equity.
Other comprehensive income decreased equity by 3,537,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs11.44 Million	+0.29%
Dividends Paid	Rs46.02 Million	-1.15%
Share Issuances	Rs1.82 Million	+0.05%
Other Comprehensive Income	Rs-3.54 Million	-0.09%
Other Changes	Rs-3.87 Million	-0.1%
Total Change	Rs-	-1.00%

Book Value vs Market Value Analysis

This analysis compares Themis Medicare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.39x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 13.13x to 2.39x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2006-03-31	Rs7.59	Rs99.73	x
2007-03-31	Rs7.53	Rs99.73	x
2008-03-31	Rs9.21	Rs99.73	x
2009-03-31	Rs9.98	Rs99.73	x
2010-03-31	Rs9.06	Rs99.73	x
2011-03-31	Rs9.89	Rs99.73	x
2012-03-31	Rs6.31	Rs99.73	x
2013-03-31	Rs5.84	Rs99.73	x
2014-03-31	Rs6.11	Rs99.73	x
2015-03-31	Rs6.40	Rs99.73	x
2016-03-31	Rs8.57	Rs99.73	x
2017-03-31	Rs13.09	Rs99.73	x
2018-03-31	Rs18.36	Rs99.73	x
2019-03-31	Rs17.18	Rs99.73	x
2020-03-31	Rs19.89	Rs99.73	x
2021-03-31	Rs23.74	Rs99.73	x
2022-03-31	Rs31.24	Rs99.73	x
2023-03-31	Rs36.82	Rs99.73	x
2024-03-31	Rs40.96	Rs99.73	x
2025-03-31	Rs43.72	Rs99.73	x
2026-03-31	Rs41.81	Rs99.73	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Themis Medicare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.29%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.33%
• Asset Turnover: 0.57x
• Equity Multiplier: 1.50x
Recent ROE (0.29%) is below the historical average (6.87%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2007	15.38%	6.00%	0.77x	3.34x	Rs37.29 Million
2008	21.25%	7.55%	0.87x	3.22x	Rs95.36 Million
2009	-12.36%	-5.29%	0.73x	3.20x	Rs-205.42 Million
2010	24.70%	9.01%	0.83x	3.31x	Rs122.51 Million
2011	10.97%	3.99%	0.85x	3.23x	Rs8.81 Million
2012	-58.17%	-21.43%	0.56x	4.81x	Rs-395.93 Million
2013	-8.88%	-2.75%	0.63x	5.09x	Rs-101.44 Million
2014	4.18%	1.20%	0.68x	5.07x	Rs-32.73 Million
2015	8.50%	2.48%	0.72x	4.74x	Rs-8.84 Million
2016	24.49%	8.30%	0.84x	3.50x	Rs114.34 Million
2017	16.18%	7.93%	0.79x	2.57x	Rs74.44 Million
2018	6.69%	5.39%	0.69x	1.81x	Rs-55.95 Million
2019	-6.79%	-5.85%	0.59x	1.99x	Rs-265.51 Million
2020	13.54%	12.29%	0.58x	1.91x	Rs64.79 Million
2021	16.34%	15.48%	0.62x	1.70x	Rs138.52 Million
2022	25.35%	18.47%	0.92x	1.49x	Rs441.32 Million
2023	16.76%	16.06%	0.69x	1.51x	Rs229.57 Million
2024	11.52%	11.40%	0.67x	1.50x	Rs57.57 Million
2025	7.41%	7.36%	0.69x	1.46x	Rs-104.27 Million
2026	0.29%	0.33%	0.57x	1.50x	Rs-387.14 Million

Industry Comparison

This section compares Themis Medicare Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $18,296,965,823
Average return on equity (ROE) among peers: 13.70%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Themis Medicare Limited (THEMISMED)	Rs3.99 Billion	15.38%	0.50x	$99.33 Million
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$1.38 Billion	2.91%	0.72x	$32.43 Million
Aarti Drugs Limited (AARTIDRUGS)	$13.69 Billion	12.28%	0.88x	$460.26 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$15.58 Billion	12.42%	0.44x	$901.84 Million
Abbott India Limited (ABBOTINDIA)	$20.09 Billion	22.42%	0.46x	$5.93 Billion
Ajanta Pharma Limited (AJANTPHARM)	$37.90 Billion	24.28%	0.32x	$4.49 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$30.64 Billion	11.04%	0.34x	$1.26 Billion
Alkem Laboratories Limited (ALKEM)	$12.05 Billion	19.50%	0.29x	$6.77 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$949.51 Million	15.88%	0.30x	$155.76 Million
Alembic Pharmaceuticals Limited (APLLTD)	$27.18 Billion	21.50%	0.76x	$1.71 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$23.50 Billion	-5.26%	1.65x	$10.54 Billion

About Themis Medicare Limited

NSE:THEMISMED India Drug Manufacturers - Specialty & Generic

Market Cap

$99.33 Million

Rs9.19 Billion INR

Market Cap Rank

#19029 Global

#1039 in India

Share Price

Rs99.73

Change (1 day)

-1.14%

52-Week Range

Rs66.07 - Rs133.07

All Time High

Rs300.15